• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Biomedical and Pharmaceutical Sciences
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2025)
Volume Volume 7 (2024)
Volume Volume 6 (2023)
Volume Volume 5 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2021)
Volume Volume 3 (2020)
Volume Volume 2 (2019)
Volume Volume 1 (2018)
Senousy, S., Ahmed, A., El-Daly, M., Khalifa, M. (2022). Cytokines in sepsis: friend or enemy?. Journal of Advanced Biomedical and Pharmaceutical Sciences, 5(1), 29-39. doi: 10.21608/jabps.2021.93867.1138
Shaymaa Ramzy Senousy; Al-Shaimaa Ahmed; Mahmoud El-Daly; Montaser Abdulhakim Khalifa. "Cytokines in sepsis: friend or enemy?". Journal of Advanced Biomedical and Pharmaceutical Sciences, 5, 1, 2022, 29-39. doi: 10.21608/jabps.2021.93867.1138
Senousy, S., Ahmed, A., El-Daly, M., Khalifa, M. (2022). 'Cytokines in sepsis: friend or enemy?', Journal of Advanced Biomedical and Pharmaceutical Sciences, 5(1), pp. 29-39. doi: 10.21608/jabps.2021.93867.1138
Senousy, S., Ahmed, A., El-Daly, M., Khalifa, M. Cytokines in sepsis: friend or enemy?. Journal of Advanced Biomedical and Pharmaceutical Sciences, 2022; 5(1): 29-39. doi: 10.21608/jabps.2021.93867.1138

Cytokines in sepsis: friend or enemy?

Article 3, Volume 5, Issue 1, January 2022, Page 29-39  XML PDF (557.33 K)
Document Type: Review Articles
DOI: 10.21608/jabps.2021.93867.1138
View on SCiNiTO View on SCiNiTO
Authors
Shaymaa Ramzy Senousy email 1; Al-Shaimaa Ahmedorcid 2; Mahmoud El-Dalyorcid 3; Montaser Abdulhakim Khalifa4
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, El-Minia, Egypt
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Egypt
3Department of Pharmacology & Toxicology, Faculty of Pharmacy, Minia University, El-Minia 61519, Egypt
4Department of Pharmacology & Toxicology, Faculty of Pharmacy, Minia University
Abstract
Infectious diseases are a major cause of death worldwide. A serious complication of infections is septic shock. Septic shock is a critical syndrome associated with the host response to infection. The severity of infections is related to an activation cascade that results in a magnification of the cytokine production which is termed "cytokine storm". Despite the commonly elucidated etiology of sepsis and its clinical course, the actual progress in therapeutic strategies is still limited. Several studies were carried out on the pathophysiology of sepsis-induced imbalance in the inflammatory/anti-inflammatory response as the main cause of tissue damage, organ failure, and eventually, death. Cytokines are crucial pleiotropic regulators of the immune response, which have an important role in the complicated pathophysiology of sepsis. They possess both pro-and anti-inflammatory properties and are capable of exerting efficacious defense responses towards invading pathogens. On the other hand, cytokines may disturb the immune response and reinforce inflammation. Thus, achieving a balance between these two effects will improve the prognosis of sepsis. Blocking the activities of pro-inflammatory cytokines promotes survival in animal models of sepsis, yet, such a treatment strategy did not enhance the clinical outcome. In this review, we will describe the mechanisms underlying the pathogenesis of the cytokine storm during sepsis and represent in detail the role of cytokines responsible for cell or organ damage. We will compare the various therapeutic approaches investigated to stop or suppress this mischievous process and discuss the reasons for therapeutic failure.
Keywords
TNF-alpha; Interleukins; immunosuppression; CLP; LPS
Main Subjects
Pharmacology and Toxicology
Statistics
Article View: 548
PDF Download: 1,039
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.